Clinical Trial Update: Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip [Phase 3]

View source ↗

Summary

Phase 3 trial assessing analgesic efficacy and safety of tanezumab added to diclofenac SR in osteoarthritis of the knee or hip; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Tanezumab (tanezumab)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED | Results posted: 2021-02-26